Blood collection ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
229	Autoimmune pulmonary alveolar proteinosis	1
271	Ankylosing spondylitis	1

229. Autoimmune pulmonary alveolar proteinosis

---

Clinical trials : 43 /  Drugs : 34 - (DrugBank : 8) / Drug target genes : 3 - Drug target pathways : 14

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04811274 (ClinicalTrials.gov)	June 7, 2021	19/3/2021	Macrophages, GM-CSF and MARS Proteinosis	Study of Macrophage Function and of the GM-CSF Signaling Pathway in Alveolar Proteinosis by Mutations of the MARS Gene	Pulmonary Alveolar Proteinosis (PAP);MARS;Genetic Mutation	Biological: Blood collection;Biological: Bronchoalveolar lavage fluid collection	Assistance Publique - Hôpitaux de Paris	NULL	Recruiting	N/A	17 Years	All	20		France

271. Ankylosing spondylitis

---

Clinical trials : 563 /  Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02809300 (ClinicalTrials.gov)	November 2015	20/6/2016	Ankylosing Spondylitis and Antiphospholipid Antibodies	Prevalence of Antiphospholipid Antibodies in Ankylosing Spondylitis: A Study of 80 Patients	Ankylosing Spondylarthritis	Biological: blood collection	CHU de Reims	NULL	Recruiting	18 Years	N/A	Both	80	N/A	France